Abstract
Modern diabetes care may benefit a significant proportion of adults living with diabetes; however, these benefits may not be consistently realized among the heterogeneous subpopulation of elderly patients over 65 years of age. There are three clinical constraints that have been proposed as important considerations for individualizing diabetes care among elderly patients. Life expectancy should be an important determinant of the intensity of glucose control because intensive control has been found to prevent complications only after extended periods of treatment. Therefore, patients with limited life expectancy may not benefit from intensive glucose control. The time and attention of health care providers should also be considered a constrained resource that can be optimally allocated to care for elderly diabetes patients. In the face of multiple chronic conditions and symptomatic complaints, patients and their providers should prioritize diabetes care within the context of a patients overall health care plan. The complexity of chronic medications or polypharmacy is the final clinical constraint. Polypharmacy may increase the probability of adverse drug events and represent a significant burden on quality of life. More direct clinical investigation of elderly diabetes patients will be needed if we are to truly improve the quality of life of this growing subpopulation.
Keywords: Diabetes, Geriatrics, Polypharmacy, Falls, Hypoglycemia
Current Diabetes Reviews
Title: Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Volume: 3 Issue: 4
Author(s): Elbert S. Huang
Affiliation:
Keywords: Diabetes, Geriatrics, Polypharmacy, Falls, Hypoglycemia
Abstract: Modern diabetes care may benefit a significant proportion of adults living with diabetes; however, these benefits may not be consistently realized among the heterogeneous subpopulation of elderly patients over 65 years of age. There are three clinical constraints that have been proposed as important considerations for individualizing diabetes care among elderly patients. Life expectancy should be an important determinant of the intensity of glucose control because intensive control has been found to prevent complications only after extended periods of treatment. Therefore, patients with limited life expectancy may not benefit from intensive glucose control. The time and attention of health care providers should also be considered a constrained resource that can be optimally allocated to care for elderly diabetes patients. In the face of multiple chronic conditions and symptomatic complaints, patients and their providers should prioritize diabetes care within the context of a patients overall health care plan. The complexity of chronic medications or polypharmacy is the final clinical constraint. Polypharmacy may increase the probability of adverse drug events and represent a significant burden on quality of life. More direct clinical investigation of elderly diabetes patients will be needed if we are to truly improve the quality of life of this growing subpopulation.
Export Options
About this article
Cite this article as:
Huang S. Elbert, Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes, Current Diabetes Reviews 2007; 3 (4) . https://dx.doi.org/10.2174/1573399810703040260
DOI https://dx.doi.org/10.2174/1573399810703040260 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Choice of Treatment with Antidepressants: Influencing Factors
Current Pharmaceutical Design Neopterin as a Marker for Immune System Activation
Current Drug Metabolism NAD in Skin: Therapeutic Approaches for Niacin
Current Pharmaceutical Design Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design Chloride Channels − New Targets for the Prevention of Stroke
Current Vascular Pharmacology Nitric Oxide-Releasing Biomaterials for Biomedical Applications
Current Medicinal Chemistry Cardiovascular Complications in Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Renin-Angiotensin-Aldosterone System: A Current Drug Target for the Management of Neuropathic Pain
Current Drug Targets Resveratrol and Its Analogues: Promising Antitumor Agents
Anti-Cancer Agents in Medicinal Chemistry Fatty Acids in Marine Organisms: In the Pursuit of Bioactive Agents
Current Pharmaceutical Analysis Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein 1: Recent Developments Concerning Substrates and Inhibitors of a Promising Therapeutic Target
Current Medicinal Chemistry Heart Failure in Sub-Saharan Africa
Current Cardiology Reviews Lifestyle Modifications in the Treatment of Hypertension
Current Hypertension Reviews Candidate Circulating Biomarkers for the Cardiovascular Disease Continuum
Current Pharmaceutical Design Approaches and Recent Trends in Gene Delivery for Treatment of Atherosclerosis
Recent Patents on Drug Delivery & Formulation Cardiovascular Disease: A Target for the Pharmacological Effects of Quercetin
Current Topics in Medicinal Chemistry Involvement of P-glycoprotein and Multidrug Resistance Associated Protein 1 in the Transport of Tanshinone IIB, a Primary Active Diterpenoid Quinone from the Roots of Salvia miltiorrhiza, Across the Blood-Brain Barrier
Drug Metabolism Letters Patent Selections:
Recent Patents on Cardiovascular Drug Discovery Regulation of Endothelial Nitric Oxide Synthase in Pathophysiological Conditions
Cardiovascular & Hematological Disorders-Drug Targets Epidemiological Characteristics of 64 Covid-19 Patients in Errachidia Province (Darâa-Tafilalet region), Morocco: A Retrospective Analysis
Reviews on Recent Clinical Trials